Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Dr Mads Gyrd-Hansen, from the Ludwig Institute for Cancer Research at the University of Oxford has received a prestigious Sapere Aude DFF-Starting Grant from the Danish Council for Independent Research, to investigate the role of ubiquitin in controlling innate immune signalling and inflammation.

Mads Gyrd-HansenThe objective of the Sapere Aude Starting Grant is to give the very best researchers who have achieved outstanding results in their field an opportunity to develop and strengthen their research ideas. 

Dr Gyrd-Hansen said: “I am honoured to have received such a prestigious grant. It will enable me to initiate a long-term and ambitious project to answer key questions about how communication in the immune system works.”

Dr Gyrd-Hansen attended an awards ceremony for the grant in Denmark on 6th February 2014 was awarded his diploma by the Danish Minister for Higher Education and Science.


Mads Gyrd-HansenImages:

Left: Dr Gyrd-Hansen with his diploma

Right: Dr Gyrd-Hansen front row, 2nd on the right, next to the Head of the Board of Directors and the Danish Minister for Higher Education and Science, front row, 4th on the left

Links:
Dr Mads Gyrd-Hansen webpage

Ludwig Institute for Cancer Research

Sapere Aude DFF-Starting Grant

Similar stories

MRC HIU appoints new Director

Awards and Appointments General

We are pleased to announce that Professor Alison Simmons has been appointed as the new Director of the MRC Human Immunology Unit.

New Year's Honours 2021

Awards and Appointments General

Members of the Medical Sciences Division have been recognised in the New Year's Honours list for 2021.

Oxford University awarded £2.4 million to fund DPhil research in inflammation, immunology and musculoskeletal disease

Awards and Appointments General

Oxford University has been awarded a £2.4 million grant, as part of the Kennedy Trust MB PhD scheme, to fund undergraduate medical students to undertake DPhil research in the areas of inflammation, immunology and musculoskeletal disease.

Professor Sir Rory Collins awarded the MRC Millennium Medal 2020

Awards and Appointments General

Professor Sir Rory Collins, Head of the Nuffield Department of Population Health, and Principal Investigator and Chief Executive of UK Biobank, has been awarded the Medical Research Council (MRC) Millennium Medal 2020, the MRC’s most prestigious personal award.

University spinout PepGen awarded major financing to target Duchenne muscular dystrophy

Awards and Appointments General Innovation

PepGen, a therapeutics company targeting severe neuromuscular diseases, including Duchenne muscular dystrophy (DMD), has closed a $45 million Series A funding round led by RA Capital Management with participation from Oxford Sciences Innovation (OSI), the company’s original seed investor.

£3M invested to drive forward early translation through five new Oxford-Bristol Myers Squibb Fellowships

Awards and Appointments General

Five new Oxford-Bristol Myers Squibb Fellowships representing an investment of £3M have been announced today*. The fellowships (formerly Oxford-Celgene) will support postdoctoral researchers and clinicians across five departments within the Medical Sciences Division and the Mathematical, Physical and Life Sciences Division, providing an opportunity for them to gain exposure to the field of commercial drug discovery and development.